Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

Détails

Ressource 1Télécharger: REF.pdf (132.45 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_B052FDB18CA6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
Périodique
Journal of Infectious Diseases
Auteur⸱e⸱s
Pilgrim  A. K., Pantaleo  G., Cohen  O. J., Fink  L. M., Zhou  J. Y., Zhou  J. T., Bolognesi  D. P., Fauci  A. S., Montefiori  D. C.
ISSN
0022-1899 (Print)
Statut éditorial
Publié
Date de publication
10/1997
Volume
176
Numéro
4
Pages
924-32
Notes
Journal Article
Research Support, U.S. Gov't, P.H.S. --- Old month value: Oct
Résumé
The role of neutralizing antibodies in human immunodeficiency virus type 1 (HIV-1) infection is poorly understood and was assessed by evaluating responses at different stages of infection. Undiluted sera from long-term nonprogressors (LTNP) had broad neutralizing antibodies against heterologous primary isolates and were more likely to neutralize the contemporaneous autologous isolate than were sera from short-term nonprogressors and progressors. In primary infection, envelope-specific IgG was detected before the initial decline in plasma viremia, but neutralizing antibodies developed more slowly. Here, neutralizing antibodies against strains SF-2 and MN were sometimes the first to be detected, but titers were low for at least 17 weeks from onset of symptoms. Neutralizing antibodies against the early autologous isolate were detected for 4 patients by 5-40 weeks but were undetectable in 2 additional patients for 27-45 weeks. The results indicate that neutralizing antibody responses are slow to develop during primary infection and are uniquely broad in LTNP.
Mots-clé
CD4 Lymphocyte Count Cells, Cultured HIV Antibodies/*analysis/*immunology HIV Infections/*immunology HIV-1/growth & development/*immunology Humans Immunoglobulin G/analysis/immunology Leukocytes, Mononuclear Macrophage Inflammatory Protein-1/analysis/immunology *Neutralization Tests RANTES/analysis/immunology Survivors Viral Load Viremia/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/01/2008 16:13
Dernière modification de la notice
14/02/2022 8:56
Données d'usage